Abstract:Objective Although it had been shown that mild or moderate hypothermia is safe in treatment of neonatal hopoxic-ischemic encephalopathy (HIE) in small scaled pilot clinical study, it is necessary to make multicentre randomized controlled trial to verify its efficacy in neonates with HIE. This multicentre randomized trial was to study the safety of selective head cooling (SHC) with mild systemic hypothermia in neonates with HIE. Methods Infants were qualified for the study if they were ≥36of weeks gestation,≥2 500 g of birth weight,and ≤6 h after birth. Cord blood gas pH ≤7. 0 or base deficit≥16 mmol ·L-1,or Apgar score ≤3 at 1 min, continued≤5 at 5 min. Neurological findings of neonatal encephalopathy included lethargy, stupor, or coma, with one or more of hypotonia, abnormal reflexes, absent or weak suck or clinical seizures. Exclusion criteria included:major congenital abnormalities, head trauma causing major intracranial hemorrhage, infection or severe anemia.Two hundred and forty-six term infants from 16 tertiary referral hospitals with various severity of neonatal encephalopathy were randomly assigned to either head cooling (n=134) or control group (n=112). In 29 babies follow up was not available (17 in cooling and 12 in control respectively). Thus 217 allocated to head cooling (n=117) and control group (n=100) respectively. In head cooling group,the nasopharyngeal temperature was maintained at (34±0. 2)℃ and rectal temperature maintained at 34 -35℃ for 72 h,then rewarmed spontaneously. In control group,normal rectal temperature was maintained. During study period,the babies in both groups were given mornitoring of nasopharyngeal temperature, heart rate, respiration rate, transcutaneous arterial oxygen saturation and blood pressure. Severe adverse events were recorded which included death, major cardiac arrhythmia, major venous thrombosis or hemorrhage and severe hypotension despite full support. Na+,K+,Ca2+,glucose, GPT,GOT,BUN,Cr,pH and BE were measured at 72h after treatment. Results The case-fatality rate was not significantly different in both groups(17.9% in cooling vs 25% in control group,P=0.20). The major cause of death was severe HIE (6. 8% in cooling vs 7% in control group,P = 0. 96) and respiratory failure (6. 8% in cooling vs 6% in control group respectively,P=0. 80) . There was one neonate with ventricular arrhythmia and DIC in control group and two neonates with DIC and severe gastrointestinal hemorrhage respectively in SHC group. The rate of severe adverse events was not signicantly different in both groups (1.7% in cooling vs 2% in control group, P = 1.00). In SHC group,most neonates had lower heart rates during the period of hypothermia,but HR below 80 beats/min was observed in only 4 cases (3.4%) . The systolic and diastolic blood pressures were stable,and no difference were found between SHC and control group. The rate of abnormal renal function, elevated liver enzyme activities, metabolic acidosis, hypoglycemia, hyperglycemia, hypocalcaemia, hyponatraemia, and hyperkalaemia were not significantly different between two groups. The average values of white blood cells, platelets, and the rate of thrombocytopenia were not significantly different between two groups. Conclusion These data suggest that selective head cooling with mild systemic hypothermia in neonates with HIE is safe during 72 h therapy.

Study the clinical manifestations and changes of neuropathology on neonates with hypoxic-ischemic encephalopathy (HIE)

Safety of selective head cooling with mild systemic hypothermia after neonatal encephalopathy:multicentre randomized trial

Changes of brain functional network in neonates with different degrees of hypoxic-ischemic encephalopathy

Changes of Serum Myelin Base Protein, Neuron Specific Enolase and Coronal-Ct Manifestions and Its Clinical Significance in Neonate Hypoxic Ischemic Encephalopathy

Changes of cerebral blood flow in neonates with hypoxic ischemic en-cephalopathy and the clinical value of prognostic evaluation of prognosis

Maternal and Fetal Risk Factors for Neonatal Hypoxic-Ischemic Encephalopathy: A Retrospective Study

Diagnostic and Follow-Up Value of CT Scan on Full-Term Neonatal Hypoxic Ischemic Encephalopathy

A clinical study on internal milieu disorder in newborn infants suffered with hypoxic ischemic encephalopathy

Prognostic Value of Electroencephalogram in Newborn with Hypoxic Ischemic Encephalopathy

CHANGES OF THE CONCENTRATIONS OF SERUM IL-8,IL-10 AND NSE IN NEONATES WITH HYPOXIC-ISCHEMIC ENCEPHALOPATHY AND THEIR CLINICAL SIGNIFICANCE

Neonatal encephalopathy: Etiologies other than hypoxic-ischemic encephalopathy

Effects of Hypothermia on Nse and S-100 Protein Levels in Csf in Neonates Following Hypoxic/Ischaemic Brain Damage

Effect of hypoxic myocardial injury on neonatal cerebral hemodynamics and brain tissue oxygen saturation

Mild hypoxic-ischemic encephalopathy (HIE): timing and pattern of MRI brain injury

Changes of functional brain network in neonates with different degrees of hypoxic-ischemic encephalopathy

Associated factors in neonatal symptomatic hypoglycemic brain injury

Genetic and Congenital Anomalies in Infants with Hypoxic-Ischemic Encephalopathy

Correlation Analysis of Neonatal Hypoxic-ischmic Encephalopathy with Myocardial Impairment

Investigate the value of diffusion weighted MRI and proton MRS in early diagnosing hypoxic-ischemic encephalopathy in full-term infants

Perinatal Risk Factors Influencing Neonatal Hypoxic Ischemic Encephalopathy in Southern China: A Case–Control Study

Early intervention and the prognosis of the neonates with hypoxic ischemic encephalopathy